TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 259 participants.

Also called NCT03357874

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 259 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03357874
  • EudraCT 2017-002839-42
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03357874. Randomized; no masking; primary purpose treatment. Start 2018-10-28 (actual); primary completion 2023-01-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TicagRelor Or Clopidogrel in Severe and Terminal Chronic Kidney Disease Patients Undergoing PERcutaneous Coronary Intervention for an Acute Coronary Syndrome.
Acronym
TROUPER
Condition
Acute Coronary Syndrome
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Ticagrelor
Lead sponsor
Assistance Publique Hopitaux De Marseille (class: other)

Record details

Record id
cardio:ct-nct03357874
Content hash
2604a12c727da0f974549cb253f553a7462939ec155a3056f520dab66ea2ebc9